reports
- ABGSC IT Research
- Daniel Thorsson
- Simon Granath
Duratec Limited: 2 directors
Two Directors at Duratec Limited bought 44,000 shares at between 1.050AUD and 1.050AUD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...
Eniro Group AB: 1 director
A director at Eniro Group AB sold 115,000,000 shares at 0.900SEK and the significance rating of the trade was 86/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
NanoXplore annonce la clôture d'une nouvelle facilité de crédit de 60 ...
NanoXplore annonce la clôture d'une nouvelle facilité de crédit de 60 millions de dollars et fait une mise à jour de son plan stratégique quinquennal MONTRÉAL, 30 avr. 2024 (GLOBE NEWSWIRE) -- NanoXplore Inc. ("NanoXplore" ou la "Société") (TSX : GRA et OTCQX : NNXPF), une entreprise de graphène de renommée mondiale, annonce la clôture d'une nouvelle facilité de crédit pour ses filiales opérationnelles avec la Banque Royale du Canada (« RBC »). En vertu de l'accord, la RBC fournira aux filiales de NanoXplore jusqu'à 60 millions de dollars canadiens. La facilité de crédit, qui regroupe ma...
U.S. Energy Corp. Announces Its Participation in the EF Hutton Annual ...
U.S. Energy Corp. Announces Its Participation in the EF Hutton Annual Global Conference HOUSTON, April 30, 2024 (GLOBE NEWSWIRE) -- U.S. Energy Corp (NASDAQ: USEG, “U.S. Energy” or the “Company”), a growth-focused energy company engaged in operating a portfolio of high-quality producing oil and natural gas assets, announced today that it will be participating in the EF Hutton Global Conference on May 15, 2024, at the Plaza Hotel in New York City. Ryan Smith, Chief Executive Officer of the Company, will host one-on-one meetings with investors at the conference. U.S. Energy is available ...
NanoXplore Announces Closing of $60M New Credit Facility and Provides ...
NanoXplore Announces Closing of $60M New Credit Facility and Provides Update on The Financing of Its 5-year Strategic Plan MONTREAL, April 30, 2024 (GLOBE NEWSWIRE) -- NanoXplore Inc. ("NanoXplore" or the "Corporation") (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, announces the closing of a new credit facility with the Royal Bank of Canada (“RBC”). Under the agreement, RBC will provide NanoXplore’s subsidiaries with up to $60M CAD. The credit facility, inclusive of an existing equipment lease and other financial products, will provide a $10M revolving credit line, u...
- Soomit Datta
AMX(Buy, TP: $24, +24%) Televisa (Neutral, $3.5, +11%) Megacable (Neut...
The market continued to eek out broadband growth in Q1, with Megacable leading the charge. We applaud management’s execution here and the double digit revenue and EBITDA growth, though this now seems embedded in expectations; we think it’s time to close out Megacable stock gains (30% YTD), trading on a 5.5% EFCF yield for 2025. Our target remains MXN55, though we have taken out the probability of cable-cable deal synergies, offset by upgrades following Q1s.
Believe S A: 1 director
A director at Believe S A sold 11,684,314 shares at 15.000EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Heal...
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference BOSTON and ROLLE, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced that Chief Financial Officer and Chief Operating Officer, Ross Muken, will present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City on Tuesday, May 14, 2024, at 3:35 p.m. EDT. The presentation will be webcast live on the . Additionally, a replay will be available on the website after its completion. About ...
Harmony Biosciences Reports Strong First Quarter Financial Results and...
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy WAKIX® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-Year Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia Planned for Second Half 2024 On Track Toward Pediatric Exclusivity to Extend WAKIX Exclusivity to September 2030: Pediatric Narcolepsy sNDA PDUFA Date of June 21, 2024; PW...
Clearside Biomedical to Report First Quarter 2024 Financial Results an...
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 ALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that its first quarter 2024 financial results will be reported on Thursday, May 9, 2024 after the close of the financial markets. Management will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the result...
Inari Amertron Bhd: 1 director
A director at Inari Amertron Bhd sold 2,000,000 shares at 0.000MYR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Šiaulių banko 2024 metų pirmojo ketvirčio finansinių rezultatų pristat...
Šiaulių banko 2024 metų pirmojo ketvirčio finansinių rezultatų pristatymo internetiniame seminare įrašas Internetiniame seminare Banko Administracijos vadovas Vytautas Sinius, Finansų tarnybos vadovas Donatas Savickas, Investicijų valdymo tarnybos vadovas Tomas Varenbergas ir vyriausioji ekonomistė Indrė Genytė-Pikčienė komentavo banko 2024 m. I ketvirčio finansinius veiklos rezultatus bei aktualijas ir po pristatymo atsakė į dalyvių klausimus. Seminaro įrašą (anglų kalba) galima peržiūrėti Nasdaq youtube paskyroje . Pristatymas ir seminaro įrašas (anglų kalba) taip pat patalpintas Banko ...
AirSculpt Technologies Announces First Quarter 2024 Earnings Release D...
AirSculpt Technologies Announces First Quarter 2024 Earnings Release Date and Conference Call MIAMI BEACH, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS), a national provider of premium body contouring procedures, today announced it will report first quarter 2024 financial results before market open on Friday, May 10, 2024, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference...
Perspective Therapeutics Selected by FDA to Participate in the CDRP Pr...
Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announces the selection of investigational product [212Pb]VMT‐α‐NET for the treatment of certain patients with neuroendocrine tumors (“NETs”) by the U.S. Food and Drug Administration (“FDA”) to participate in the Chemistry, Manufactur...
ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity...
ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies Study results support differentiation of PMN310 from other amyloid-beta-directed antibodies CAMBRIDGE, Massachusetts and TORONTO, Ontario, April 30, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA)...
LGI Homes Reports First Quarter 2024 Results
LGI Homes Reports First Quarter 2024 Results THE WOODLANDS, Texas, April 30, 2024 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced financial results for the three months ended March 31, 2024. First Quarter 2024 Highlights Home sales revenues of $390.9 millionHome closings of 1,083Average sales price per home closed of $360,897Gross margin as a percentage of home sales revenues of 23.4%Adjusted gross margin (non-GAAP) as a percentage of home sales revenues of 25.3%Net income before income taxes of $23.1 millionNet income of $17.1 million, or $0.72 basic EPS and $0....
ZeroFox Threat Intelligence and Attack Surface Experts to Present at 2...
ZeroFox Threat Intelligence and Attack Surface Experts to Present at 2024 RSA Conference ZeroFox to showcase external cybersecurity platform with newly-released external attack surface management module WASHINGTON, April 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ZFOX), a leading provider of external cybersecurity, is exhibiting and speaking at the 2024 RSA Conference in San Francisco, California from May 6-9th. Visit ZeroFox at Booth 1135 to learn how to see and secure all external assets with ZeroFox’s External Attack Surface Management solution, which is generally available as of today. ...
Aclaris Therapeutics to Announce First Quarter 2024 Financial Results ...
Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update WAYNE, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced it will report financial results for the first quarter 2024 on Tuesday, May 7, 2024, after the closing of the U.S. financial markets. Management will conduct a conference call at 5:00 p.m. ET on the same day to provide a corporate update. The confere...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.